Analgesics (Pharmacies) - Ukraine

  • Ukraine
  • Revenue in the Analgesics market is projected to reach US$0.41bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.18%, resulting in a market volume of US$0.58bn by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$10.86 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Ukraine has been experiencing steady growth in recent years.

Customer preferences:
Customers in Ukraine have shown a growing preference for over-the-counter analgesics, which can be easily purchased at pharmacies without a prescription. This trend is driven by several factors. Firstly, the convenience of purchasing analgesics without a prescription allows customers to quickly and easily obtain relief for common ailments such as headaches, muscle pain, and fever. Secondly, the affordability of over-the-counter analgesics makes them accessible to a wider range of consumers. Lastly, the increasing awareness and education about self-care and self-medication have contributed to the growing demand for over-the-counter analgesics.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Ukraine is the increasing demand for non-opioid analgesics. This can be attributed to the global concern over the opioid crisis and the efforts to reduce the use of opioids for pain management. As a result, customers are seeking alternative pain relief options that are non-addictive and have fewer side effects. Non-opioid analgesics such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen have gained popularity among consumers in Ukraine. Another trend in the market is the growing demand for natural and herbal analgesics. Customers are becoming more conscious of the ingredients and potential side effects of pharmaceutical products. As a result, there is an increasing interest in natural and herbal remedies for pain relief. This trend is also influenced by the global shift towards natural and organic products in various industries, including healthcare.

Local special circumstances:
One of the factors that contribute to the development of the Analgesics (Pharmacies) market in Ukraine is the country's aging population. As the population ages, the prevalence of chronic pain conditions such as arthritis and back pain increases. This drives the demand for analgesics among older consumers who seek relief from their pain symptoms. Additionally, the increasing urbanization and sedentary lifestyle in Ukraine have led to a rise in musculoskeletal disorders, further fueling the demand for analgesics.

Underlying macroeconomic factors:
The economic growth in Ukraine has also played a role in the development of the Analgesics (Pharmacies) market. As the country's economy improves, consumers have more disposable income to spend on healthcare products, including analgesics. The increasing healthcare expenditure and improving healthcare infrastructure in Ukraine have also contributed to the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Ukraine is developing due to customer preferences for over-the-counter analgesics, the increasing demand for non-opioid and natural remedies, the country's aging population, and the underlying macroeconomic factors such as economic growth and improving healthcare infrastructure.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)